HomeCTABF • OTCMKTS
add
Canntab Therapeutics Ord Shs
Previous close
$0.00010
Market cap
194.45K CAD
Avg Volume
4.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Feb 2023info | Y/Y change |
|---|---|---|
Revenue | -22.16K | — |
Operating expense | 179.37K | — |
Net income | -412.63K | — |
Net profit margin | 1.86K | — |
Earnings per share | — | — |
EBITDA | -92.77K | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Feb 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.81K | — |
Total assets | 953.54K | — |
Total liabilities | 3.11M | — |
Total equity | -2.16M | — |
Shares outstanding | 38.91M | — |
Price to book | -0.00 | — |
Return on assets | -35.51% | — |
Return on capital | -3,454.56% | — |
Cash Flow
Net change in cash
| (CAD) | Feb 2023info | Y/Y change |
|---|---|---|
Net income | -412.63K | — |
Cash from operations | -37.69K | — |
Cash from investing | -2.78K | — |
Cash from financing | 1.97K | — |
Net change in cash | -38.50K | — |
Free cash flow | 149.47K | — |
About
Founded
2010
Headquarters
Website
